about MDR-TB and no any data about the prevalence of XDR-TB in Zahedan, we decided to evaluate them.
From January 2007 to January 2008, we evaluated all patients with a positive sputum culture who referred to our hospital (Research Center for Infectious Diseases and Tropical Medicine). First, all patients who had clinical signs and symptoms suggestive of PTB were enrolled. These patients were asked to participate in our study. If they accepted, they underwent testing including Ziehl-Neelsen staining and culture. Patients who subsequently were culture-negative for Mycobacterium tuberculosis were withdrawn from the study. Then, we analyzed all culture-positive cases of Mycobacterium tuberculosis infection referred to our TB center. Primary isolation and culture of Mycobacterium isolates, after NaOH-N-acetylcysteine was done in conformity with standard solid-culture procedures. 13 All isolates were identified as M. tuberculosis complex with use of standard biochemical tests, including niacin activity, production of catalase and nitrate reduction, as well as the registration of pigment production and growth rate. Drug susceptibility testing against isoniazid and rifampicin was done by the proportional method on Lo¨wenstein-Jensen media at a concentration of 0.1 and 0.001 mg/mL.
14 Drug-susceptibility testing against second-line drugs (amikacin, kanamycin, capreomycin, ciprofloxacin, levofloxain) was carried out using 2 critical proportions of 0.1 and 0.001. All of these drugs were purchased from glaxo Chemical. Clinical and Epidemiological Information collected from patients with confirmed cases of TB by trained technicians using standard questionnaires. Information obtained on sex, age, previous history of TB, present address, and associated medical data such as chest radiograph findings and presence of HIV infection. Patients also required to have drug-susceptibility test results that showed resistance to isoniazid and rifampin (as MDR-TB), as well as chest radiograph findings and clinical signs and symptoms that were compatible with PTB. Statistical analysis was performed using SPSS, version 11. Data were analyzed by Chi-Square test and p<0.05 was considered significant.
This prospective study was conducted using a total of eighty eight patients (40% male, 60% female) with positive sputum culture for M. tuberculosis complex. The patients aged between 15 and 94 years. 90% of patients were Iranian and 10% wer Afghan. 12.2% of our patients had MDR-TB (3 females; 6 males) and one subject with pre-XDR-TB (resistant to capreomycin) identified. No case had XDR-TB. 8% of culture positive patients had a negative sputum smear and two cases had HIV infection. Ten patients (8.8%) had a past history of treatment for tuberculosis. Among previously treated patients, 44% had MDR-TB. Among patients who had received a new diagnosis, 10% had MDR-TB.
Our results showed that 12.2% of our patients had MDR-TB. One patient with pre-XDR-TB (capreomycin resistanse) identified; and there was no case of XDR-TB. Tuberculosis is a serious public health problem in Iran as other developing countries and MDR-TB is a very important and serious health problem among patients with tuberculosis.
9,10 Extensively drug-resistant tuberculosis has also recently emerged as a global health problem, threatening the success of TB control programs in the world. 7, 15, 16 There are many reports which show MDR and XDR-TB are increasing worldwide. Recent studies in Iran also showed that both MDR and XDR-TB were increasing especially among patients treated within inappropriate regimens or when patients became selectively non-compliant by not taking all of the 3 or 4 drugs. 4 7 Shamimi and his colleagues reported 2% of 548 patients had MDR-TB. 17 Another study in Southeast Iran by Naserpour and colleages showed that 16% of patients with PTB had MDR-TB. 8 There was no any XDR-TB among patients in these two recent studies. A global survey in reference laboratories for TB isolates during 2000-2004 identified XDR-TB in 17 countries and estimated that10% of the sampled multidrug-resistant (MDR) TB strains were XDR. 18 A study in California during 1993-2006, identified 18 XDR-TB cases who had poor outcomes. None of the patients in California with XDR-TB had AIDS. 19 In conclusion, 12.2% of patients had MDR-TB. There was no patient with XDR-TB in our study. We recommend drug-susceptibility testing on the firstline drugs in any patient with tuberculosis in the beginning of treatment. 
